ClinicalTrials.govpublic full text
Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease
parkinson's disease, neurogenic bladder, urinary incontinence, clostridium botulinum toxin adverse reaction, botulinum toxin, cystoscopy, effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825990
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.